DRAP
The new article describes in detail the approach to be followed when it comes to the assessment of adverse events.
DRAP
The new article describes the basics of international collaboration, aimed at further improvement of the regulatory framework and establishing a more efficient information exchange in order to ensure the proper performance of healthcare products as well as the safety of patients.
DRAP
The final article of the cycle provides additional details regarding specific indicators used in the context of a pharmacovigilance system.
DRAP
The new article elaborates further on the existing types of surveillance, highlighting the key points associated thereto.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now
